home / stock / ogn / ogn news


OGN News and Press, Organon & Co. From 02/12/26

Stock Information

Company Name: Organon & Co.
Stock Symbol: OGN
Market: NYSE
Website: organon.com

Menu

OGN OGN Quote OGN Short OGN News OGN Articles OGN Message Board
Get OGN Alerts

News, Short Squeeze, Breakout and More Instantly...

OGN - Organon outlines flat $6.2B revenue and $1.9B EBITDA targets for 2026 as cost controls and portfolio shifts take center stage

2026-02-12 10:45:34 ET More on Organon Organon & Co. (OGN) Q4 2025 Earnings Call Transcript Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon falls as women&#...

OGN - Organon & Co. (OGN) Q4 2025 Earnings Call Transcript

2026-02-12 10:44:42 ET Organon & Co. (OGN) Q4 2025 Earnings Call February 12, 2026 8:30 AM EST Company Participants Jennifer Halchak - Head of Investor Relations Joseph Morrissey - Interim CEO & Executive VP and Head of Manufacturing & Supply Matthew Wa...

OGN - Organon in charts: Q4 revenue from Women's Health and Established Brands down; Biosimilars up Y/Y

2026-02-12 07:59:16 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon Non-GAAP EPS of $0.63 misses by $0.10, revenue of $1.51B in-line Organon ...

OGN - Earnings Snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook

2026-02-12 07:52:12 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon Non-GAAP EPS of $0.63 misses by $0.10, revenue of $1.51B in-line Organon ...

OGN - Organon Non-GAAP EPS of $0.63 misses by $0.10, revenue of $1.51B in-line

2026-02-12 07:32:02 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon Q4 Earnings Preview: Cautious view amid weak year Earnings week ahead: F,...

OGN - Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

Full year 2025 revenue of $6.2 billion, down 3% on both an as-reported basis and at constant currency Full year 2025 diluted earnings per share of $0.72 and non-GAAP Adjusted diluted earnings per share of $3.66 Full year 2025 Adjusted EBITDA of $1.91 billion inclusive of $6 million of IPR...

OGN - Expected US Company Earnings on Thursday, February 12th, 2026

Baxter International Inc. (BAX) is expected to report $0.53 for Q4 2025 Nova Ltd. (NVMI) is expected to report $1.94 for Q4 2025 West Pharmaceutical Services Inc. (WST) is expected to report $1.83 for Q4 2025 Universal Logistics Holdings Inc. (ULH) is expected to report $-0.05 for Q4 ...

OGN - Organon Q4 Earnings Preview: Cautious view amid weak year

2026-02-11 11:17:39 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more ...

OGN - Earnings week ahead: F, KO, CSCO, SHOP, MCD, BP, AMAT, COIN, MRNA, ROKU, and more

2026-02-08 08:07:00 ET Earnings season continues with another busy, market-moving week ahead, as companies across autos, consumer staples, technology, healthcare, energy, utilities, financials, REITs, and materials step into the spotlight.... Read the full article on Seeking Alpha ...

OGN - Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026

Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its fourth quarter and full year 2025 financial results on February 12, 2026, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET. IPR&D and Mile...

Previous 10 Next 10